AR070031A1 - Sistemas de administracion transdermicos de droga ketotifen y metodos para el tratamiento de enfermedades oftalmicas - Google Patents

Sistemas de administracion transdermicos de droga ketotifen y metodos para el tratamiento de enfermedades oftalmicas

Info

Publication number
AR070031A1
AR070031A1 ARP080104724A ARP080104724A AR070031A1 AR 070031 A1 AR070031 A1 AR 070031A1 AR P080104724 A ARP080104724 A AR P080104724A AR P080104724 A ARP080104724 A AR P080104724A AR 070031 A1 AR070031 A1 AR 070031A1
Authority
AR
Argentina
Prior art keywords
ketotifen
treatment
methods
administration systems
ophthalmic diseases
Prior art date
Application number
ARP080104724A
Other languages
English (en)
Spanish (es)
Original Assignee
Teikoku Pharma Usa Inc
Senju Usa Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teikoku Pharma Usa Inc, Senju Usa Inc filed Critical Teikoku Pharma Usa Inc
Publication of AR070031A1 publication Critical patent/AR070031A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00361—Plasters
    • A61F2013/00544—Plasters form or structure
    • A61F2013/00646—Medication patches, e.g. transcutaneous
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00361—Plasters
    • A61F2013/00655—Plasters adhesive
    • A61F2013/00659—Plasters adhesive polymeric base
    • A61F2013/00663—Plasters adhesive polymeric base acrylic

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ARP080104724A 2008-05-30 2008-10-29 Sistemas de administracion transdermicos de droga ketotifen y metodos para el tratamiento de enfermedades oftalmicas AR070031A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5774808P 2008-05-30 2008-05-30
US12/236,392 US20090297590A1 (en) 2008-05-30 2008-09-23 Ketotifen transdermal drug delivery systems and methods for treating ophthalmic disease

Publications (1)

Publication Number Publication Date
AR070031A1 true AR070031A1 (es) 2010-03-10

Family

ID=41377403

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080104724A AR070031A1 (es) 2008-05-30 2008-10-29 Sistemas de administracion transdermicos de droga ketotifen y metodos para el tratamiento de enfermedades oftalmicas

Country Status (9)

Country Link
US (1) US20090297590A1 (enExample)
EP (1) EP2296748B1 (enExample)
JP (1) JP2011523650A (enExample)
KR (1) KR20110019382A (enExample)
CN (1) CN102083494B (enExample)
AR (1) AR070031A1 (enExample)
ES (1) ES2458627T3 (enExample)
TW (1) TW200948401A (enExample)
WO (1) WO2009145801A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5241714B2 (ja) 2006-07-07 2013-07-17 プロテウス デジタル ヘルス， インコーポレイテッド スマートな非経口送達システム
EP2211974A4 (en) 2007-10-25 2013-02-27 Proteus Digital Health Inc INFORMATION SYSTEM FOR LIQUID FLOW CHANNEL
WO2009067463A1 (en) 2007-11-19 2009-05-28 Proteus Biomedical, Inc. Body-associated fluid transport structure evaluation devices
AU2011210648B2 (en) 2010-02-01 2014-10-16 Otsuka Pharmaceutical Co., Ltd. Data gathering system
MY169700A (en) 2010-02-01 2019-05-13 Proteus Digital Health Inc Data gathering system
US20130060209A1 (en) * 2011-05-12 2013-03-07 Parker Campbell Tyler Athletic Tape
US8900626B2 (en) 2011-06-20 2014-12-02 Senju Usa, Inc. Transdermal drug delivery system and method of using the same
WO2014028396A2 (en) * 2012-08-13 2014-02-20 Hicken Matthew Therapeutic elastic tape
CA2894696A1 (en) * 2012-12-21 2014-06-26 Teikoku Pharma Usa, Inc. Compositions and methods for transdermal delivery of hormones and other medicinal agents
WO2016124601A1 (en) * 2015-02-02 2016-08-11 Santen Pharmaceutical Co., Ltd Polyaphrons and palpebral administration thereof
USD890936S1 (en) 2018-05-25 2020-07-21 Blacktop Plus, Llc Therapeutic elastic sports tape

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2512805B2 (ja) * 1989-07-14 1996-07-03 積水化学工業株式会社 ケトチフェン経皮吸収製剤
JP2879362B2 (ja) * 1990-08-07 1999-04-05 富山化学工業株式会社 ケトチフェンのプラスター剤
JP4205778B2 (ja) * 1998-04-17 2009-01-07 久光製薬株式会社 貼付製剤
US20030104041A1 (en) * 1999-12-16 2003-06-05 Tsung-Min Hsu Transdermal and topical administration of drugs using basic permeation enhancers
KR100433614B1 (ko) * 2000-06-16 2004-05-31 주식회사 태평양 친수성 또는 염의 형태로 된 약물을 함유하는 경피흡수제제
JP4213432B2 (ja) * 2002-08-28 2009-01-21 久光製薬株式会社 貼付剤
KR20050092429A (ko) * 2003-01-22 2005-09-21 니찌방 가부시기가이샤 안질환 치료용 경피 흡수형 제제, 그 사용, 및 안질환치료약의 눈의 국소 조직으로의 이행 방법
JPWO2005115355A1 (ja) * 2004-05-28 2008-03-27 久光製薬株式会社 貼付製剤
WO2006036899A2 (en) * 2004-09-27 2006-04-06 Corium International, Inc. Transdermal systems for the delivery of estrogens and progestins
JP5075334B2 (ja) * 2004-11-22 2012-11-21 久光製薬株式会社 薬物含有貼付剤
WO2006114868A1 (ja) * 2005-04-20 2006-11-02 Nichiban Co., Ltd. 経皮吸収製剤
WO2006124749A2 (en) * 2005-05-13 2006-11-23 Alza Corporation Multilayer drug delivery system with barrier against antagonist exposure
KR100835074B1 (ko) * 2006-09-27 2008-06-03 조선대학교산학협력단 멜록시캄 경피 흡수제 조성물 및 그의 제조 방법

Also Published As

Publication number Publication date
WO2009145801A1 (en) 2009-12-03
JP2011523650A (ja) 2011-08-18
CN102083494A (zh) 2011-06-01
KR20110019382A (ko) 2011-02-25
EP2296748A4 (en) 2011-09-28
EP2296748B1 (en) 2014-04-02
CN102083494B (zh) 2013-11-13
EP2296748A1 (en) 2011-03-23
US20090297590A1 (en) 2009-12-03
TW200948401A (en) 2009-12-01
ES2458627T3 (es) 2014-05-06

Similar Documents

Publication Publication Date Title
CY1123255T1 (el) Σχημα δοσολογιας για εναν αγωνιστη υποδοχεα s1p
ES2543977T3 (es) Sistema terapéutico transdérmico para la administración del principio activo buprenorfina
UY31975A (es) Sistema y administración transdérmica de estrógeno
AR097045A2 (es) Sistema terapéutico transdérmico
CY1116638T1 (el) Διαδερμικο θεραπευτικο συστημα για την χορηγηση μιας δραστικης ουσιας
CO6491052A2 (es) Compuestos espirociclicos que contienen notrogeno y su uso medicinal
CY1120283T1 (el) Διαδερμικο θεραπευτικο συστημα για την χορηγηση ριβαστιγμινης ή παραγωγων αυτης
CL2012003281A1 (es) Uso de compuestos específicos estimuladores y/o activadores de sgc; formulacion farmaceutica que comprende dichos compuestos; kit que comprende los compuestos, y uso para la prevencion y/o tratamiento de la esclerosis sistematica.
BRPI0714712B8 (pt) dispositivo para administração de fármaco
CR20140321A (es) Sistema de administracion transdermica que contiene buprenofina
CY1114363T1 (el) Ανθελμινθικος συνδυασμος
MX2009012273A (es) Dispositivos de suministro transd?rmico que aseguran la liberaci?n mejorada de un principio activo a trav?s de una interfaz biol?gica.
CO6511251A2 (es) Compuestos quimicos
CL2008003406A1 (es) Compuestos derivados de quinolina; composicion farmaceutica que los comprende; y uso en el tratamiento de una infeccion por vih.
SV2010003451A (es) Derivados de pirimidina trisustituida para el tratamiento de enfermedades proliferativas
BRPI0507210A (pt) dispositivo que impede o uso indevido para administração transdérmica de opióide
AR058598A1 (es) Administracion transdermica de meptazinol
MX2019007389A (es) Sistema terapeutico transdermico que contiene asenapina y polisiloxano o poliisobutileno.
EA201400628A1 (ru) Трансдермальная терапевтическая система для введения фентанила или его аналога
BR112012018449A2 (pt) tira dental para administração de tratamento oral
CO6561765A2 (es) Composiciones trandérmicas de propinilaminoindan
ATE402663T1 (de) Flächiges implantat
ECSP14010605A (es) Sistema para la administración de fármacos
MX362908B (es) Implantes que contienen fármacos y métodos de uso de los mismos.
EA201300648A1 (ru) Трансдермальная терапевтическая система (tts), содержащая ротиготин

Legal Events

Date Code Title Description
FB Suspension of granting procedure